Q3 FY2026 · ended Sep 30, 2026 · Revenue $38.40M, +11.0% YoY · Filed Nov 4, 2026
NRC Health (NRC) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $38.4 million and net income of $4.7 million. Free cash flow was $7.0 million. As of Sep 30, 2026 it held $3.6 million in cash and investments and $102.9 million in total debt.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- NRC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lincoln, NE
- SEC filer status
- Accelerated filer
- SEC CIK
- 70487
- Former names
- NATIONAL RESEARCH CORP (until Mar 27, 2026)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $38.4M | $35.4M | $34.8M | $35.2M | $34.6M |
| Operating income | $8.9M | -$3.2M | $5.6M | $4.7M | $7.7M |
| Net income | $4.7M | -$3.3M | — | — | — |
| Diluted EPS | $0.21 | -$0.15 | $0.14 | $0.08 | $0.18 |
| Operating cash flow | $8.0M | $1.4M | $7.2M | $7.2M | $13.8M |
| Free cash flow | $7.0M | $62,000 | $5.3M | $6.1M | $10.2M |
| Total assets | $139.2M | $136.2M | $134.6M | $134.9M | $135.7M |
| Total liabilities | $148.3M | $129.6M | $121.1M | $120.9M | $121.4M |
| Stockholders' equity | -$9.1M | $6.5M | $13.5M | $14.0M | $14.3M |
| Cash and investments | $3.6M | $3.3M | $2.5M | $4.1M | $2.2M |
| Total debt | $102.9M | $90.0M | $74.0M | $76.2M | $76.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2026 | Jul 28, 2026 |
All 1001 NRC Health SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.